Chronic Pain Clinical Trial
Official title:
Brief-Illness Perception Questionnaire (Brief-IPQ) Used as Prediction of Outcome in Patients With Chronic Non-malignant Pain After Treatment in a Multidisciplinary Pain Clinic
NCT number | NCT05535335 |
Other study ID # | REG-1303-2022 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 6, 2020 |
Est. completion date | April 3, 2022 |
Verified date | March 2022 |
Source | Zealand University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The investigators wish to investigate if there are any difference in the BIPQ score in persons with chronic low back pain from admission to the Pain Centre at Zealand University Hospital Koege (ZUH), and when discharged.
Status | Completed |
Enrollment | 364 |
Est. completion date | April 3, 2022 |
Est. primary completion date | April 3, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 100 Years |
Eligibility | Inclusion Criteria: - Patients admitted to the multidisciplinary pain clinic at Zealand University Hospital with low back pain - Understand Danish spoken and written Exclusion Criteria: - Patients with insufficient cognitive abilities - Patients who decline to participate in the study |
Country | Name | City | State |
---|---|---|---|
Denmark | Zealand University Hospital | Køge | Zealand |
Lead Sponsor | Collaborator |
---|---|
Zealand University Hospital |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Differences in Fear Avoidance | Change in Fear avoidance will be measured by using the 17 items Tampa Scale of Kinesiophobia, Scores range from 17 to 68. Low scores indicate no kinesiophobia and high scores extreme fear of pain with movement. Cut off score = 37. | Change in Fear avoidance will be measured at admission and at discharge between the 12-6-2020 - 03-04-2022 | |
Other | Differences in Quality of life | Change in Quality of life will be measured by using the PROMIS-10 questionnaire.Using T-scores, median = 50, higher scores over 50 indicates wellbeeing. | Change in Quality of life will be measured at admission and at discharge between the 12-6-2020 - 03-04-2022 | |
Other | Differences in Pain Self efficacy | Change in Pain Self efficacy will be measured by using the 2 items fra 10 item questionnaire: PSEQ. PSEQ 1 and PSEQ 2. numbers are calculated by summing the numbers. Median = 3, Scores higher than 3 means high confidence, lower than 3 means low confidence. | Change in Pain Selv Efficacy will be measured at admission and at discharge between the 12-6-2020 - 03-04-2022 | |
Other | Differences in Pain Catastrophizing | Change in Pain Catastrophizing will be measured by using the 13 items Pain Catastrophizing Scale. PCS range from 0 to 52. Subclinical = 0 to 29; Mild = 30 to 39; Moderate = 40 to 49; Severe = 50 to 59; Extreme = 60 to 100. | Change in Pain Catastrophizing will be measured at admission and at discharge between the 12-6-2020 - 03-04-2022 | |
Other | Differences in Numeric rating scale | Change in Pain intensity during movement measured from 0-10, where 10 is the worst pain | Change in Pain intensity during movement measured at admission and at discharge between the 12-6-2020 - 03-04-2022 | |
Primary | Differences in illness perception | Change in Brief Illness perception will be measured by using the Brief Illness perception questionnaire. The IPQ-B consists of nine items rated on a scale from 0 (minimum) to 10 (maximum). Illness perception Scores 0-24, low scores, 24-56 moderate, 56- 80 high scores. | Change in Illness peception score Measured at admission and at discharge between the 12-6-2020 - 03-04-2022 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|